Caliper CBD, the only clinically proven fast-acting CBD
While CBD has recently become a star in the supplement world, there remains a significant lack of clinical scientific studies on its bioavailability in humans. With only 3% of nearly 800 recent studies conducted with human participants, and a disappointing 13%-19% oral bioavailability suggested in oral CBD supplements, Caliper set out to to exam the bioavailability of its product in the first ever human clinical trail of commercially available CBD. The results of this study speak for themselves, with the study suggesting significantly more bioavailability of Caliper's water-soluble CBD compared to oil-soluble solutions.

Check out this download to learn more about these human clinical bioavailability trials of Caliper's commercially available CBD.